| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0006 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |